Predictors of coronary stent thrombosis: a case–control study

To verify the frequency and predictors associated with stent thrombosis (ST) in a developing country. Observational, case–control study including 2535 consecutive patients undergoing percutaneous coronary intervention (PCI) in two reference hospitals in Brazil, from October 2013 to December 2015. ST patients were matched to controls in a 1:3 ratio for gender, age, procedure indication, and performing hospital. From the total sample, 65 (2.5%) ST occurred and were matched with 195 controls (age 64.9 ± 11.8 years; hypertension, 78.8%; diabetes, 30%). Clopidogrel and aspirin early withdrawal (OR 19.25; 95% CI 1.66–23.52; p < 0.01 and OR 4.36; 95% CI 1.81–10.50; p = 0.001, respectively), hypertension (OR 3.64; 95% CI 1.38–9.61; p = 0.006), dyslipidemia (OR 2.84; 95% CI 1.48–5.45; p = 0.002), smoking (OR 3.09; 95% CI 1.28–7.43; p = 0.02), body mass index ≥ 30 kg/m² (OR 2.10; 95% CI 1.02–4.49; p = 0.012), previous myocardial infarction (OR 2.98; 95% CI 1.14–7.47; p < 0.001), bifurcation lesion (OR 2.44; 95% CI 1.05–5.67; p = 0.03), and ≥ 3 stents (OR 3.90; 95% CI 1.78–8.52; p = 0.002) were associated with ST. Stent type, diameter or length, severity of coronary artery disease, calcified lesions, and thrombus were not associated with ST. We found a similar frequency of ST from developed countries and identified strong predictors (clopidogrel and aspirin withdrawal, hypertension, dyslipidemia, smoking, obesity, previous myocardial infarction, bifurcation lesion, number of stents), which are in line with reports from developed countries.